Tracey Roberts

447 total citations
5 papers, 343 citations indexed

About

Tracey Roberts is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tracey Roberts has authored 5 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 2 papers in Critical Care and Intensive Care Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tracey Roberts's work include Clostridium difficile and Clostridium perfringens research (5 papers), Antibiotic Resistance in Bacteria (2 papers) and Nosocomial Infections in ICU (2 papers). Tracey Roberts is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (5 papers), Antibiotic Resistance in Bacteria (2 papers) and Nosocomial Infections in ICU (2 papers). Tracey Roberts collaborates with scholars based in United States and Canada. Tracey Roberts's co-authors include Joseph Sliman, Heidi Whalen, John F. Kokai‐Kun, Brian A. Potoski, Gary Blank, Lee H. Harrison, David L. Paterson, Peter Veldkamp, R L Simmons and A. William Pasculle and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and The Lancet Infectious Diseases.

In The Last Decade

Tracey Roberts

5 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tracey Roberts United States 5 305 198 96 63 34 5 343
Fabian K. Berger Germany 11 212 0.7× 115 0.6× 54 0.6× 89 1.4× 42 1.2× 32 325
Andreas Karas United Kingdom 8 261 0.9× 208 1.1× 39 0.4× 44 0.7× 23 0.7× 16 320
Jeanne Couturier France 10 250 0.8× 149 0.8× 47 0.5× 56 0.9× 31 0.9× 34 323
Kristin Nagaro United States 9 388 1.3× 279 1.4× 51 0.5× 52 0.8× 22 0.6× 13 434
Sofie M. van Dorp Netherlands 9 337 1.1× 195 1.0× 52 0.5× 79 1.3× 17 0.5× 12 370
Travis J Carlson United States 14 241 0.8× 187 0.9× 38 0.4× 78 1.2× 81 2.4× 34 395
Papanin Putsathit Australia 17 560 1.8× 287 1.4× 79 0.8× 107 1.7× 20 0.6× 33 644
James R. Osmolski United States 9 282 0.9× 194 1.0× 40 0.4× 31 0.5× 43 1.3× 10 382
N Iwai Japan 7 345 1.1× 246 1.2× 38 0.4× 42 0.7× 35 1.0× 44 449
Paolo Carfagna Italy 11 219 0.7× 181 0.9× 31 0.3× 33 0.5× 39 1.1× 24 331

Countries citing papers authored by Tracey Roberts

Since Specialization
Citations

This map shows the geographic impact of Tracey Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracey Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracey Roberts more than expected).

Fields of papers citing papers by Tracey Roberts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracey Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracey Roberts. The network helps show where Tracey Roberts may publish in the future.

Co-authorship network of co-authors of Tracey Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of Tracey Roberts. A scholar is included among the top collaborators of Tracey Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracey Roberts. Tracey Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Kokai‐Kun, John F., Tracey Roberts, Chenxiong Le, et al.. (2019). Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial. The Lancet Infectious Diseases. 19(5). 487–496. 59 indexed citations
2.
Kokai‐Kun, John F., Tracey Roberts, Éric Sicard, et al.. (2017). The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies. Antimicrobial Agents and Chemotherapy. 61(3). 57 indexed citations
3.
Kokai‐Kun, John F., et al.. (2017). SYN-004 (ribaxamase) prevents New Onset Clostridium difficile Infection by Protecting the Integrity Gut Microbiome in a Phase 2b Study. Open Forum Infectious Diseases. 4(suppl_1). S12–S12. 6 indexed citations
4.
Roberts, Tracey, John F. Kokai‐Kun, Heidi Whalen, et al.. (2016). Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies. Clinical Drug Investigation. 36(9). 725–734. 26 indexed citations
5.
Muto, Carlene A., Jane W. Marsh, Emanuel N. Vergis, et al.. (2007). Control of an Outbreak of Infection with the Hypervirulent Clostridium difficile BI Strain in a University Hospital Using a Comprehensive "Bundle" Approach. Clinical Infectious Diseases. 45(10). 1266–1273. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026